About Rosemarie Hunziker
Form D filings for Morphoceuticals from 2023 to 2024 list Rosemarie Hunziker as director.
Rosemarie Hunziker first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Rosemarie Hunziker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rosemarie Hunziker works with at each company, as listed on that company's latest Form D.
Morphoceuticals, Inc. · Form D, Oct 7, 2024
MH
Michael Hufford
Director
AP
Alexander Pickett
Director
JB
Justin Briggs
Director
TT
Tamim Al-Thani
Director
JJ
James Jenson
Chief Executive Officer and director